The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.
Genes and environment determine short-sightedness.
Shares of Novartis were down 0.7 percent at 74.55 Swiss francs in mid-morning trading on the Six Swiss stock exchange.
The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.
Alcohol and bacon are some of the key culprits.
Asthma is a chronic condition that affects more than 25 million people in the United States alone.
Under the terms of the agreement, argenx will conduct research and development through IND-enabling studies.
Novartis published their first quarter financial report, which included information on bimagrumab, a drug developed in conjunction with Morphosys to treat a muscle-wasting disease called sporadic inclusion body myositis (sIBM).
This disease marks the third treatment indication GW is pursuing.
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.
The drug risperidone has been successful in reducing serious behavioral problems in children with autism spectrum disorder (ASD), but researchers have discovered that increased appetite, followed by weight gain, can be a undesirable adverse effect.
The team’s review looked at all of the available data including five randomized trials and forty two observational studies of colorectal, breast and prostate cancers.
T cells are the immune system's natural defense against cancer and other harmful entities in the human body.
Vice President Joe Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data in an effort to accelerate ambitious cancer research goals, at the American Association for Cancer Research annual meeting.